Hey, John: can you comment on the AstraZeneca/Gameleya cooperation agreement announced recently? As a virologist who works for Big Pharma, you might have insights, I figure.
One question that occurs to me: why bother? By the time they can validate a combined protocol of their two vaccines, won't there be 8 or so vaccines already approved and on the market? I figure two or three from China, J&J, Novavax, and at least three others.
Hey, John: can you comment on the AstraZeneca/Gameleya cooperation agreement announced recently? As a virologist who works for Big Pharma, you might have insights, I figure.
One question that occurs to me: why bother? By the time they can validate a combined protocol of their two vaccines, won't there be 8 or so vaccines already approved and on the market? I figure two or three from China, J&J, Novavax, and at least three others.